Home
Live Updates
Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results : comparemela.com
Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results
/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a biopharmaceutical company with three clinical programs in development and a strong...
Related Keywords
Ukraine ,
Jon Faiz Kayyem ,
Kimberly Manhard ,
Douglas Forsyth ,
Securities Exchange ,
Aventis Inc ,
Inhibrx Inc ,
Party Transactions ,
Company On ,
Inhibrx Biosciences Inc ,
Nasdaq ,
Prnewswire Inhibrx Inc ,
Exchange Commission ,
Inhibrx Biosciences ,
New Inhibrx ,
Company Employees ,
Currently Subject ,
Company Wide Blackout Restricting ,
Inhibrx Stock ,
Merger Consideration ,
Merger Agreement ,
Looking Statements ,
Middle East ,
Annual Report ,
Quarterly Reports ,
Current Reports ,
Private Securities Litigation Reform Act ,
Securities Exchange Act ,
Employee Director Compensation ,
Regulations K ,
Securities Act ,
Related Party ,
Certain Beneficial Owners ,
Beneficial Ownership ,
Kristiina Vuori ,
Media Contact ,
Consolidated Statements ,
comparemela.com © 2020. All Rights Reserved.